Illness Anxiety Disorder: Symptoms, Diagnosis, and Treatment
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Illness anxiety disorder (IAD) is a clinical mental health condition characterized by persistent preoccupation with having or acquiring a serious illness, high anxiety about health, and excessive health-related checking or maladaptive avoidance. Bodily symptoms are absent or mild, although the person can also have an actual medical condition. Under the DSM-5-TR, the illness preoccupation must persist for at least six months, and the specific disease feared may change over time. See the American Psychiatric Association diagnostic chapter and the 2026 Merck Manual clinical review.
The defining clinical problem is persistent illness-related fear and the consequences it has for attention, behavior, relationships, and daily life. An individual may worry that an ordinary body sensation indicates cancer, heart disease, or a neurological condition. Reassurance may provide temporary relief before a new doubt appears. Other individuals avoid medical appointments because the possibility of bad news is overwhelming. Neither behavior by itself establishes a diagnosis.
Illness anxiety disorder can be treated. Cognitive behavioral therapy (CBT) has the largest established evidence base for severe health anxiety, while medication and structured medical follow-up may be appropriate according to individual circumstances. Good care combines a medically sound evaluation with attention to persistent anxiety. An IAD diagnosis never means that future physical symptoms can be dismissed without appropriate assessment.
This article explains the symptoms, DSM-5-TR diagnostic requirements, differences from ICD-11, clinical differentials, psychological mechanisms, assessment, treatment evidence, recovery, safety considerations, practical implications, and common questions. It is an educational resource and cannot diagnose an individual reader.
What Is Illness Anxiety Disorder?
The core experience is fear that a serious illness exists or may develop. A minor rash may provoke a persistent concern about cancer; normal awareness of the heartbeat may be interpreted as cardiac danger; a fleeting headache may prompt worry about a brain tumor. The person may spend hours checking, researching, asking for reassurance, or thinking about potential consequences. A medical examination can provide meaningful information, yet uncertainty may quickly return.
IAD is classified in the Somatic Symptom and Related Disorders chapter of the DSM-5-TR. The diagnosis belongs to a defined clinical classification, whereas health anxiety describes a wider spectrum of experiences ranging from ordinary concern to substantial impairment. Someone awaiting biopsy results or managing a chronic illness can experience understandable worry without meeting the requirements for IAD.
Some people have a recognized medical disease, a significant family history, or an objectively elevated risk. Those realities must be integrated into assessment. The presence of diagnosed physical illness does not automatically rule out clinically excessive illness anxiety, and the presence of illness anxiety does not establish that a physical symptom is harmless.
Health anxiety, hypochondria, and hypochondriasis
Health anxiety is a broadly used psychological term. Illness anxiety disorder is the specific DSM-5-TR diagnosis. Hypochondria is a historical and popular word that is frequently stigmatizing when used casually. Hypochondriasis was a diagnosis in earlier classifications and remains a formal ICD-11 term with its own criteria and organization. Clinicians should state which system they are using rather than treat the labels as perfect synonyms.
Symptoms and Behavioral Patterns
A person's illness fear may stay focused on one disease or move repeatedly between possibilities. The symptoms may fluctuate with new health information, stress, medical appointments, or experiences of illness in the family. IAD commonly involves a combination of cognitive preoccupation, emotional alarm, and behavior intended to protect against feared illness.
Repeated fear of serious disease
The feared event may be a missed diagnosis, permanent disability, death, or being unable to care for loved ones. A person may think frequently about what a symptom could mean, compare sensations with disease descriptions, rehearse catastrophic outcomes, or revisit the possibility that previous testing was incomplete.
Heightened attention to body sensations
Ordinary fluctuations in heartbeat, breathing, digestion, skin appearance, or muscle activity may become unusually salient. Once attention is directed toward a sensation, the person may notice it more often. The increased attention can be mistaken for evidence that the problem has become more serious.
Checking, searching, and monitoring
Repeated body checking may involve measuring pulse, palpating lymph nodes, examining moles, taking photographs, checking blood pressure without a medical reason, or repeatedly researching symptoms. Some checking is medically appropriate; the diagnostic concern is repetitive behavior whose main purpose is temporary relief from uncertainty and whose consequences sustain distress. Research on health-anxiety beliefs and safety-seeking behavior supports examining these patterns (Abramowitz et al., 2007).
Reassurance seeking and repeated consultations
People may frequently ask doctors or family members whether a symptom is dangerous, request another opinion immediately after a thorough assessment, or repeatedly revisit normal test results. Relief may last minutes or days. A new doubt about the sensitivity of a test or the possibility of a rare illness then renews anxiety.
Avoidance of healthcare
Other people avoid medical information, routine care, hospital settings, test results, or contact with people who are ill. Avoidance can delay necessary treatment or prevention. Clinicians distinguish care-seeking and care-avoidant patterns when specifying the DSM-5-TR diagnosis.
Disruption of daily life
Severe illness anxiety can affect sleep, work, relationships, finances, schooling, and recreation. The person may devote large amounts of time to investigating medical possibilities, withdraw from commitments, or seek constant family reassurance. Distress and impairment are assessed in their clinical and cultural context.
DSM-5-TR Diagnostic Criteria
A clinician establishes IAD by evaluating a recognizable constellation of features, not by interpreting a single complaint or screening score. The following summary reflects the DSM-5-TR Somatic Symptom and Related Disorders chapter.
Persistent illness preoccupation
The person is preoccupied with having or acquiring a serious illness. The feared condition may change during the clinical course.
Absent or mild somatic symptoms
Physical symptoms, when present, are generally mild. Where a diagnosed medical condition or elevated risk exists, the person's illness preoccupation is excessive or disproportionate in its actual medical context. This criterion requires competent medical judgment.
High health anxiety
Anxiety about health is substantial, and the person is readily alarmed by personal health information or bodily changes.
Excessive health-related behavior or maladaptive avoidance
The pattern includes repeated health checks, persistent reassurance seeking, or avoidance of medical care and other relevant reminders. Clinicians consider whether behaviors are genuinely unnecessary or medically indicated before characterizing them as excessive.
At least six months of illness preoccupation
Preoccupation has persisted for at least six months. It may concern different feared diseases over that period. Brief fear after a new symptom does not, by itself, meet the duration requirement.
Differential diagnostic requirement
The overall disturbance cannot be better explained by another mental disorder, including somatic symptom disorder, panic disorder, generalized anxiety disorder, obsessive-compulsive disorder, body dysmorphic disorder, or delusional disorder of somatic type. Relevant comorbid diagnoses may still be made when their full criteria are present.
Care-seeking and care-avoidant specifiers
The care-seeking presentation involves frequent healthcare use and repeated consultation. The care-avoidant presentation involves avoidance of health services despite fear. These specifiers describe current patterns rather than fixed identities, and behavior can change over time.
DSM-5-TR vs ICD-11 Classification
DSM-5-TR uses the category illness anxiety disorder and places it with somatic symptom and related disorders. The World Health Organization's ICD-11 includes hypochondriasis, code 6B23, in the obsessive-compulsive and related disorders grouping, with secondary parenting in anxiety or fear-related disorders and specifiers addressing level of insight. See the official WHO ICD-11 Clinical Descriptions and Diagnostic Requirements.
The categories address overlapping clinical territory involving illness fear, preoccupation, and health-related behavior. Their classification placement and criteria differ. Researchers and clinicians should not presume an automatic one-to-one equivalence between an individual DSM-5-TR IAD diagnosis and an ICD-11 hypochondriasis diagnosis. This matters when interpreting international prevalence estimates and older treatment studies.
Historical research frequently enrolled people meeting DSM-IV hypochondriasis criteria or broader severe health-anxiety definitions. These populations provide relevant treatment evidence while remaining distinct from a sample confirmed exclusively by DSM-5-TR IAD criteria.
IAD vs Somatic Symptom Disorder
The primary focus of IAD is fear of having or acquiring a serious disease when bodily symptoms are absent or mild. Somatic symptom disorder (SSD) involves one or more distressing or disruptive physical symptoms combined with excessive symptom-related thoughts, feelings, or behaviors. Physical symptoms may be prominent, persistent, and disabling in SSD.
Both conditions can involve anxiety, healthcare use, and bodily attention. Neither diagnosis requires deception or fabrication. A person with a real medical condition can meet criteria for SSD if the relevant psychological and behavioral features are present. The clinical distinction is made through the full pattern of symptoms, concerns, behavior, impairment, and medical evaluation (DSM-5-TR).
For example, a person with minimal bodily discomfort but months of fear that cancer has been overlooked might warrant assessment for IAD. Someone living with substantial and distressing physical symptoms may require an SSD assessment in parallel with appropriate physical investigations. Such examples illustrate diagnostic reasoning, not rules for self-diagnosis.
IAD vs OCD and Other Anxiety-Related Conditions
Obsessive-compulsive disorder can include intrusive fears about contamination, harm, disease, or responsibility, accompanied by compulsive rituals. Repeated health checking appears in both OCD and IAD, but its relationship to the entire syndrome matters. The Hub's published OCD vs Illness Anxiety Disorder article discusses this differential in detail.
Panic disorder involves recurrent unexpected panic attacks and concern about attacks or their consequences. A panic attack may cause fear of a heart attack, while IAD more characteristically involves prolonged preoccupation with a serious illness outside a discrete episode. Both conditions can coexist.
Generalized anxiety disorder involves persistent difficult-to-control worry across multiple domains, whereas IAD has a predominantly illness-focused preoccupation. Clinical assessment considers the breadth, content, and function of worry. A related overview is available in the Hub's Anxiety Disorders clinical guide.
Depression, body dysmorphic disorder, delusional disorder, trauma-related symptoms, medication effects, and medical illness may contribute to an overlapping presentation. The specific diagnosis depends on the full assessment rather than any one behavior such as searching symptoms on the internet.
Why Does Illness Anxiety Disorder Develop?
There is no single universally demonstrated cause. Clinicians use an individualized formulation of vulnerabilities, health-related events, interpretations, attention, behavior, and maintaining processes. Cognitive-behavioral models are especially useful because they identify processes that can be changed during treatment.
Threat interpretations and bodily attention
A person may interpret a harmless physiological variation as evidence of a severe illness. Anxiety increases attention to bodily events, which makes further sensations easier to detect. Those sensations can then appear to confirm the initial fear. The experience of the sensation and anxiety is real, even when the feared disease is not established.
Intolerance of medical uncertainty
Some individuals believe that responsible health behavior requires absolute certainty that no disease is present. Because medicine deals in evidence, probability, monitoring, and changing clinical information, absolute certainty is rarely available. Repeated attempts to remove every doubt can increase distress and interfere with ordinary life.
Safety behaviors and reassurance cycles
Checking, searching, asking for reassurance, or avoiding triggers may lower anxiety in the short term. Repetition can keep illness threat at the center of attention and make uncertainty harder to tolerate. This mechanism is consistent with cognitive-behavioral research on health anxiety and with the targets of effective therapy (Salkovskis et al., 2002; Abramowitz et al., 2007).
Personal experiences and environmental influences
A frightening diagnosis in the family, previous illness, a difficult medical investigation, uncertainty about inherited disease, and high exposure to health-related information may contribute in particular cases. Stress can intensify fear. These possible factors are neither diagnostic criteria nor proven universal causes, and the presence of trauma does not establish the cause of an individual case.
The role of digital information
Online health information can help people seek timely and appropriate care. When searching becomes an escalating, repetitive attempt to remove all uncertainty, it may reinforce fear. The clinical question concerns purpose, repetition, impairment, and accuracy of information, rather than simply whether the person uses the internet.
Clinical Assessment and Diagnosis
A good evaluation takes both physical health and emotional distress seriously. A primary care clinician reviews the medical concern and determines what examination or targeted testing is appropriate. A mental health clinician assesses illness preoccupation, behavior, duration, impairment, psychiatric differentials, and any co-occurring depression or anxiety. The Mayo Clinic diagnostic overview describes the combination of medical and psychological assessment.
Medical history and physical examination
The history includes symptom onset, severity, progression, medical diagnoses, family history, medications, risk factors, and previous workups. Testing should answer actual medical questions. A clinician decides when additional investigation is warranted and when repeated testing offers little clinical benefit. New or changing symptoms remain eligible for medical reassessment.
Psychological interview
Clinicians ask what diseases the person fears, how much time is spent worrying, what behaviors follow a triggering sensation, whether reassurance brings lasting relief, and whether healthcare is sought or avoided. They consider life impact, insight, mood, panic symptoms, OCD symptoms, substance use, stressors, and safety.
Health-anxiety scales and screening
The Health Anxiety Inventory and Short Health Anxiety Inventory measure severity of health anxiety and can help track change. Their initial validation showed useful measurement properties (Salkovskis et al., 2002). A systematic review and meta-analysis supported the SHAI as an assessment measure while identifying variability in structure, cutoff values, and generalizability. Scores depend on version, population, and setting.
No questionnaire result alone establishes IAD, excludes a medical disease, or decides the necessary clinical intervention. Screening indicates a possible need for a fuller assessment.
Coordinated formulation and follow-up
An effective plan identifies the clinician coordinating physical healthcare, the treatment targets for health anxiety, reasonable follow-up intervals, what constitutes a concerning new symptom, and how progress will be evaluated. Medical treatment and psychological treatment can proceed together when both are needed.
Medical Differentials and Safety
Actual disease may coexist with IAD. New chest pain, significant difficulty breathing, sudden weakness, stroke-like changes, unexplained major bleeding, or severe acute neurological symptoms may warrant urgent evaluation. A prior psychiatric diagnosis does not reduce the obligation to investigate an important change in clinical presentation.
Physical conditions can also generate sensations that increase anxiety. Thyroid disease, arrhythmias, medication effects, neurologic conditions, and many other medical problems may be relevant depending on the person. A general article cannot specify which tests are needed for a particular symptom. That decision belongs to an appropriately qualified professional.
A person living with cancer, chronic disease, or a known genetic risk may reasonably require ongoing monitoring and professional information. Treatment for excessive illness anxiety should preserve indicated screening, medication, appointments, and diagnostic workups.
Evidence-Based Treatment
The goals of care are to reduce sustained illness preoccupation, lessen anxiety-driven checking and avoidance, improve functioning, and develop a sound relationship with medical uncertainty. The strongest randomized-trial evidence is for CBT for substantial health anxiety. Other psychological methods and medication have evidence with differing certainty, and clinical planning responds to individual needs.
Cognitive behavioral therapy
CBT examines the relationship between bodily sensations, feared interpretation, anxiety, safety behaviors, and the longer-term consequences of reassurance or avoidance. Patients and therapists agree on experiments that test assumptions about danger and reduce unhelpful repetitive behavior without compromising medical care.
A 2019 systematic review and meta-analysis by Axelsson and Hedman-Lagerlöf found clinically relevant benefits of CBT compared with non-CBT controls for health anxiety. In a 2026 network meta-analysis by Lai and colleagues, 35 randomized trials with 3,263 participants were analyzed. Multiple psychological intervention approaches showed benefits relative to waiting-list controls. The trials involved substantial health anxiety and related diagnostic categories, so their pooled outcomes should not be described as a treatment estimate for DSM-5-TR IAD alone.
Exposure and response prevention
Exposure may involve safely approaching illness-related information, sensations, or situations that have become feared, while changing repeated checking, unnecessary reassurance, and avoidant behavior. An example is postponing repeated checking of a benign sensation after an appropriate medical evaluation, following a therapist's individualized plan. Exposure does not mean ignoring medically significant symptoms or discontinuing necessary monitoring.
The 2026 network meta-analysis assessed treatment components including exposure and response prevention (Lai et al.). Its conclusions support the use of relevant elements within individualized health-anxiety treatment, not a claim that OCD and IAD are the same disorder.
Cognitive change, attention, and uncertainty
Therapy may address the assumption that any unknown bodily sensation must be dangerous or that the only responsible action is to obtain total certainty. Work can include more balanced interpretation of probabilities, flexible response to uncertainty, changes in selective bodily attention, and gradual return to valued daily activities. The objective is proportionate action based on medical evidence.
Acceptance-based and other psychological interventions
Acceptance and commitment therapy, mindfulness-related approaches, metacognitive approaches, and behavioral stress management have been investigated for health anxiety. The 2026 network meta-analysis provides comparative evidence, while heterogeneity of samples and protocols limits claims of universal superiority for any single therapy. Care should be adapted to preferences, accessibility, and co-occurring conditions.
Therapist-guided internet CBT
Research supports structured online delivery in some adults. A 2020 randomized noninferiority trial involving 204 adults compared therapist-guided internet CBT with face-to-face CBT for health anxiety. The online format was noninferior for the prespecified primary outcome and used fewer resources. The result concerns a structured clinical intervention and cannot be generalized to all self-help apps or general-purpose conversational AI systems.
Medications
Selective serotonin reuptake inhibitors may help some people with illness anxiety disorder or closely related severe health anxiety, particularly when co-occurring anxiety or depression is present. A 2017 randomized trial by Fallon and colleagues compared fluoxetine, CBT, combined therapy, and placebo among 195 people with DSM-IV hypochondriasis. The evidence informs treatment but is not an exclusively DSM-5-TR IAD study. The 2026 Merck Manual review also discusses serotonin reuptake inhibitors.
Medication selection depends on diagnosis, expected benefit, side effects, interactions, previous treatment, comorbid conditions, and patient preference. Prescriptions should be initiated, reviewed, adjusted, or discontinued with a qualified healthcare professional.
Continuing medical care
A stable primary care relationship can reduce fragmented and duplicative investigations while maintaining appropriate assessment of real symptoms. Follow-up plans specify when a new symptom should prompt medical contact and when a previously evaluated concern can be addressed through the psychological treatment plan. The Mayo Clinic treatment guidance describes psychotherapy, medication when appropriate, and coordinated healthcare.
Prognosis and Long-Term Outcomes
The course varies. Health anxiety can remain persistent, fluctuate with stress, or improve substantially with treatment. Recovery involves less time devoted to feared disease, greater tolerance of uncertainty, reduced repetitive reassurance-seeking, improved participation in life, and appropriate use of healthcare.
A randomized CHAMP trial with outcomes through five years found sustained health-anxiety improvements after specialized CBT compared with standard care in a medical-outpatient population. Participants were enrolled using older hypochondriasis-related definitions; results cannot guarantee the same long-term course for every person with DSM-5-TR IAD. Treatment may require adaptation when medical problems or comorbid psychiatric conditions complicate care.
Practical Guidance for Patients and Families
When preparing for an appointment, describe the feared illness, which sensations or information trigger alarm, how frequently checking occurs, whether appointments are repeated or avoided, and how the pattern affects daily functioning. Clinicians can then address both actual medical needs and the anxiety process. Recording patterns for a visit is useful; continuous symptom logging can become another form of unhelpful checking.
Work with the primary care clinician to determine which screening and monitoring are indicated, which symptoms require timely consultation, and when follow-up should occur. Keep necessary preventive care and established medical treatment. Avoid relying on repeated online searches as a substitute for a coherent clinical plan.
Family members can provide warmth and practical support while reducing participation in endless reassurance rituals when advised by a treating professional. The aim is a supportive response to real distress alongside appropriate medical judgment. Restoring work, recreation, sleep, and relationships helps make illness fear less central to daily life.
Children and Adolescents
Health-related anxiety also occurs in young people, but clinical evaluation must consider developmental stage, family responses, school functioning, pediatric medical history, and the child's ability to describe feared illness. Worries may show up as repeated questions, absences from school, avoidance of activities, or requests for reassurance. None of these alone constitutes a diagnosis.
Assessment can involve a pediatrician and mental health professional, with appropriate medical investigation and consideration of anxiety, OCD, and relevant physical conditions. Family-centered work and coordinated school support may be appropriate. The Canadian Paediatric Society's 2024 guidance supports careful pediatric assessment and management. Adult IAD trials should not automatically be treated as proof of treatment effects in children.
When to Seek Professional or Urgent Help
A clinical consultation is appropriate when illness worries have persisted, checking or avoidance is difficult to control, medical appointments are repeatedly driven by fear, or daily functioning is affected. A primary care clinician can review physical symptoms and coordinate further assessment. Mental health professionals can evaluate the pattern and discuss treatment.
Seek urgent medical care for potentially dangerous new symptoms such as severe chest pain, serious breathing difficulty, stroke-like changes, or abrupt major neurological changes. Existing IAD does not establish that a new event is anxiety-related. In an immediate mental health safety emergency, contact local emergency or crisis services.
Frequently Asked Questions
Is illness anxiety disorder a formal diagnosis?
Yes. It is a DSM-5-TR diagnosis within Somatic Symptom and Related Disorders. Its criteria concern sustained illness preoccupation, high health anxiety, associated behavior or avoidance, limited somatic symptom burden, duration, and differential diagnosis.
Can I have IAD if I really have a medical illness?
Yes. Actual disease and clinically significant health anxiety may coexist. Clinicians consider whether illness concern is disproportionate in its medical context, and indicated medical care continues.
What is the difference between IAD and health anxiety?
Health anxiety is a broad experience that can occur without mental disorder. IAD is a formal syndrome diagnosed only when its full clinical requirements are met.
How long does IAD have to last?
DSM-5-TR requires persistent illness preoccupation for at least six months. The particular illness feared may change during that time.
Is IAD another name for hypochondria?
Hypochondria is a popular historical term. DSM-5-TR uses illness anxiety disorder. ICD-11 uses the formal category hypochondriasis, with classification differences that should be preserved.
Are physical symptoms made up in IAD?
No. Bodily sensations, anxiety, and distress can be entirely real. IAD concerns illness preoccupation and its clinical context; it does not presume fabrication or deliberate deception.
What is the difference between IAD and somatic symptom disorder?
IAD emphasizes illness fear with absent or mild physical symptoms. SSD involves one or more prominent distressing physical symptoms and associated excessive thoughts, feelings, or behaviors. Both require assessment in the presence of any actual medical conditions.
Is IAD a form of OCD?
The conditions overlap in some checking and reassurance behaviors but have different diagnostic requirements. Co-occurrence is possible. ICD-11 and DSM-5-TR place the related diagnoses in different classification groupings.
Does a normal blood test prove I have IAD?
No. A normal test provides information about the medical question investigated. Diagnosis requires an evaluation of the sustained psychological and behavioral pattern and relevant differentials.
Can stress cause IAD?
Stress can worsen illness preoccupation and may contribute to its development in some people. There is no single established cause, and trauma is not a required criterion.
Which psychotherapy has the best evidence?
CBT has the largest evidence base for substantial health anxiety. Exposure and response prevention can be useful components when adapted to the person's medical context.
Can internet CBT help?
Structured therapist-guided internet CBT showed noninferior results relative to face-to-face CBT in one randomized trial of adults with health anxiety. Results should not be generalized to all websites or chatbots.
Can medication help with IAD?
SSRIs may be useful in some cases. Evidence includes trials in related hypochondriasis populations, and prescribing requires individualized medical assessment.
Should people with IAD stop visiting doctors?
No. Necessary preventive care, prescribed follow-up, and evaluation of important new symptoms continue. Treatment targets unnecessary repetitive checking and harmful avoidance.
Can illness anxiety disorder get better?
Yes. Clinical trials support improvement with CBT, sometimes maintained during long-term follow-up. The course differs among individuals and may require continuing support.
For broader clinical context, see Somatic Symptom and Functional Disorders: Types, Diagnosis, and Treatment.
Related Articles
Read the Hub's OCD vs Illness Anxiety Disorder comparison for diagnostic differences involving compulsions and health fears. Neuroticism and Health Anxiety addresses a related personality vulnerability. Anxiety Disorders: Symptoms, Types, Diagnosis, and Treatment and How Is Anxiety Diagnosed? provide broader clinical context.
References
Abramowitz, J. S., Deacon, B. J., & Valentiner, D. P. (2007). The Short Health Anxiety Inventory: Psychometric properties and construct validity in a non-clinical sample. Cognitive Therapy and Research, 31, 871–883. DOI.
Alberts, N. M., Hadjistavropoulos, H. D., Jones, S. L., & Sharpe, D. (2013). The Short Health Anxiety Inventory: A systematic review and meta-analysis. Journal of Anxiety Disorders, 27(1), 68–78. DOI.
American Psychiatric Association. (2022). Somatic symptom and related disorders. Diagnostic and Statistical Manual of Mental Disorders, 5th ed., text rev. DSM-5-TR chapter DOI.
Axelsson, E., Andersson, E., Ljótsson, B., Björkander, D., Hedman-Lagerlöf, M., & Hedman-Lagerlöf, E. (2020). Effect of internet vs face-to-face cognitive behavior therapy for health anxiety: A randomized noninferiority clinical trial. JAMA Psychiatry, 77(9), 915–924. DOI.
Axelsson, E., & Hedman-Lagerlöf, E. (2019). Cognitive behavior therapy for health anxiety: Systematic review and meta-analysis of clinical efficacy and health economic outcomes. Expert Review of Pharmacoeconomics & Outcomes Research, 19(6), 663–676. DOI.
Canadian Paediatric Society. (2024). Somatic symptom and related disorders: Guidance on assessment and management. Official guidance.
Fallon, B. A., Ahern, D. K., Pavlicova, M., Slavov, I., Skritskaya, N., & Barsky, A. J. (2017). A randomized controlled trial of medication and cognitive-behavioral therapy for hypochondriasis. American Journal of Psychiatry, 174(8), 756–764. DOI.
Lai, L., Liu, Y., Axelsson, E., Tyrer, P., Li, Y., Lu, Y., Shi, C., & Ren, Z. (2026). The comparative effectiveness of psychological interventions for health anxiety: Systematic review and a network meta-analysis of randomised controlled trials. British Journal of Psychiatry. DOI.
Mayo Clinic. (2021). Illness anxiety disorder: Diagnosis and treatment. Official clinical guide.
Merck Manual Professional Edition. (2026). Illness anxiety disorder. Reviewed June 2026. Professional clinical review.
Salkovskis, P. M., Rimes, K. A., Warwick, H. M. C., & Clark, D. M. (2002). The Health Anxiety Inventory: Development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychological Medicine, 32(5), 843–853. DOI.
Tyrer, P., et al. (2017). Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): A randomised controlled trial with outcomes to 5 years. Health Technology Assessment, 21(50), 1–58. DOI.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Official WHO publication.